Trials / Conditions / Schizophrenia, Schizoaffective Disorder

Schizophrenia, Schizoaffective Disorder

7 registered clinical trials studyying Schizophrenia, Schizoaffective Disorder — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With S NCT06319170	Teva Branded Pharmaceutical Products R&D LLC	Phase 1
Completed	A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerb NCT04512066	Hoffmann-La Roche	Phase 2
Recruiting	Brain Imaging of Cognition Inn Schizophrenia and Depression NCT04159662	The Royal Ottawa Mental Health Centre	—
Terminated	A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective NCT03669640	Hoffmann-La Roche	Phase 2
Unknown	Topiramate and Schizophrenia: Effects on Weight and Psychopathology NCT02808533	Centre for Addiction and Mental Health	N/A
Completed	Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations NCT02192593	Boston University Charles River Campus	N/A
Completed	Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial NCT00224315	Central Institute of Mental Health, Mannheim	Phase 4